apelin-17



apelin-17

K1KK1F2FF2R3RR3R4RR4Q5QQ5R6RR6P7PP7R8RR8L9LL9S10SS10H11HH11K12KK12G13GG13P14PP14M15MM15P16PP16F17FF17

SMILES None
InChIKey SVWSKJCJNAIKNH-MJZUAXFLSA-N
Sequence KFRRQRPRLSHKGPMPF

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)


Bioactivities

apelin-17

K1KK1F2FF2R3RR3R4RR4Q5QQ5R6RR6P7PP7R8RR8L9LL9S10SS10H11HH11K12KK12G13GG13P14PP14M15MM15P16PP16F17FF17

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0


Compound is not listed as a drug.